Onodera Y, Saitoh Y, Nagai K
Dept. of Neurosurgery, Mito Red-Cross Hospital.
Gan No Rinsho. 1987 Oct;33(12):1402-6.
The diagnostic value of immunoglobulin G in cerebrospinal fluid (CSF-IgG) has been evaluated in patients with brain tumors. The (CSF-IgG) level in patients with malignant brain tumors was found to be significantly elevated when compared to the level in control patients without a disorder of the central nerve system. Especially significant was high level of CSF-IgG found in patients whose tumor had invaded into ventricles. The CSF-IgG level was found to decrease to a normal range by a total or subtotal resection of the tumor, but not by partial resection. On the other hand, CSF which contained large amount of IgG inhibited the lymphocyte proliferative response to phytomitogen. These results suggest that CSF-IgG seems to correlate with the tumor volume, and is important as a tumor marker in patients with a malignant brain tumor.
已对脑肿瘤患者脑脊液免疫球蛋白G(CSF-IgG)的诊断价值进行了评估。结果发现,与没有中枢神经系统疾病的对照患者相比,恶性脑肿瘤患者的(CSF-IgG)水平显著升高。尤其值得注意的是,肿瘤侵犯脑室的患者CSF-IgG水平很高。发现通过肿瘤全切或次全切,CSF-IgG水平可降至正常范围,但部分切除则不能。另一方面,含有大量IgG的脑脊液抑制了淋巴细胞对植物有丝分裂原的增殖反应。这些结果表明,CSF-IgG似乎与肿瘤体积相关,并且作为恶性脑肿瘤患者的肿瘤标志物具有重要意义。